These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26668818)

  • 1. Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease.
    Mammen AL; Casciola-Rosen L; Christopher-Stine L; Lloyd TE; Wagner KR
    Neurol Neuroimmunol Neuroinflamm; 2015 Dec; 2(6):e172. PubMed ID: 26668818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
    Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
    Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
    Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A
    Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera.
    Cavazzana I; Fredi M; Ceribelli A; Mordenti C; Ferrari F; Carabellese N; Tincani A; Satoh M; Franceschini F
    J Immunol Methods; 2016 Jun; 433():1-5. PubMed ID: 26906088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies.
    Xu Q; Li QX; Bi FF; Duan HQ; Luo YB; Yang H
    Clin Rheumatol; 2021 Feb; 40(2):613-624. PubMed ID: 32671659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies.
    Ghirardello A; Gatto M; Franco C; Zanatta E; Padoan R; Ienna L; Gallo N; Zen M; Lundberg IE; Mahler M; Doria A; Iaccarino L
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
    Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N;
    J Autoimmun; 2019 Jul; 101():48-55. PubMed ID: 30992170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China.
    Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y
    Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myositis-specific autoantibodies in clinical practice: Improving the performance of the immunodot.
    Bories E; Fortenfant F; Pugnet G; Renaudineau Y; Bost C
    Semin Arthritis Rheum; 2022 Aug; 55():151998. PubMed ID: 35427882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune Myopathies.
    Mahler M; Malyavantham K; Seaman A; Bentow C; Anunciacion-Llunell A; Sanz-Martínez MT; Viñas-Gimenez L; Selva-O'Callaghan A
    Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age distribution and prevalence in different age groups of four myositis-specific autoantibodies, including anti-ARS, anti-MDA5, anti-Mi-2, and anti-TIF1γ antibodies.
    Ueda-Hayakawa I; Tonomura K; Maekawa A; Kaneda E; Arase N; Fujimoto M
    J Dermatol; 2023 Aug; 50(8):1058-1062. PubMed ID: 36890683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies.
    Pinal-Fernandez I; Milisenda JC; Pak K; Muñoz-Braceras S; Casal-Dominguez M; Torres-Ruiz J; Dell'Orso S; Naz F; Gutierrez-Cruz G; Duque-Jaimez Y; Matas-Garcia A; Padrosa J; Garcia-Garcia FJ; Guitart-Mampel M; Garrabou G; Trallero-Araguás E; Walitt B; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Grau-Junyent JM; Selva-O'Callaghan A; Mammen AL
    Ann Rheum Dis; 2023 Aug; 82(8):1091-1097. PubMed ID: 37130727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two clusters of systemic lupus erythematosus patients with muscle involvement in a Chinese cohort.
    Zhao L; Huang W; Wang H; Chen J; Zhang D; Wang X; Sun F; Ye S
    Int J Rheum Dis; 2023 Jan; 26(1):51-59. PubMed ID: 36117395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan.
    Iwata N; Nakaseko H; Kohagura T; Yasuoka R; Abe N; Kawabe S; Sugiura S; Muro Y
    Mod Rheumatol; 2019 Sep; 29(5):802-807. PubMed ID: 30092736
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myositis-specific antibodies associated with juvenile dermatomyositis].
    Eising K; Peitz J; Unterwalder N; Meisel C; Horneff G
    Z Rheumatol; 2018 Oct; 77(8):735-740. PubMed ID: 29411095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis.
    Pinal-Fernandez I; Casal-Dominguez M; Derfoul A; Pak K; Miller FW; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Carrion-Ribas C; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
    Ann Rheum Dis; 2020 Sep; 79(9):1234-1242. PubMed ID: 32546599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis.
    Aouizerate J; De Antonio M; Bader-Meunier B; Barnerias C; Bodemer C; Isapof A; Quartier P; Melki I; Charuel JL; Bassez G; Desguerre I; Gherardi RK; Authier FJ; Gitiaux C
    Rheumatology (Oxford); 2018 May; 57(5):873-879. PubMed ID: 29474663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent research on myositis-specific autoantibodies in juvenile dermatomyositis.
    He L
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1064-1068. PubMed ID: 34719424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort.
    Loganathan A; Gupta L; Rudge A; Lu H; Bowler E; McMorrow F; Naveen R; Anuja AK; Agarwal V; McHugh N; Tansley S
    Rheumatology (Oxford); 2024 Sep; 63(9):2363-2371. PubMed ID: 38479813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies.
    Hosono Y; Sie B; Pinal-Fernandez I; Pak K; Mecoli CA; Casal-Dominguez M; Warner BM; Kaplan MJ; Albayda J; Danoff S; Lloyd TE; Paik JJ; Tiniakou E; Aggarwal R; Oddis CV; Moghadam-Kia S; Carmona-Rivera C; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Christopher-Stine L; Larman HB; Mammen AL
    Ann Rheum Dis; 2023 Feb; 82(2):246-252. PubMed ID: 36008132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.